लोड हो रहा है...
Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV(−) and HPV(+) Head and Neck Cancers To TNFα, TRAIL, and Radiation Therapy
PURPOSE: Human papilloma virus (HPV) negative head and neck squamous cell carcinomas (HNSCC) harbor frequent genomic amplification of Fas-Associated Death Domain (FADD), with or without concurrent amplification of Baculovirus inhibitor of apoptosis repeat containing (BIRC2/3) genes encoding cellular...
में बचाया:
| में प्रकाशित: | Clin Cancer Res |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825532/ https://ncbi.nlm.nih.gov/pubmed/31266830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3802 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|